After a week of highs and lows, the index ended the five sessions essentially where it started. And it remains less than 3% away from a record.

The Nifty experienced a setback, failing to sustain a breakout from its month-long consolidation phase, closing with a weekly ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...